Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 4.660
-0.236 (-4.82%)
Sep 11, 2026, 4:35 PM GMT
Shield Therapeutics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Shield Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of 17p. The average 1-year stock price forecast is 257.73% higher than the current stock price, while the lowest is 12p (+157.51%) and the highest is 23p (+393.56%).
Price Target: 17p (+257.73%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Shield Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
71.87M
from 49.70M
Increased by 44.59%
Revenue Next Year
93.95M
from 71.87M
Increased by 30.73%
EPS This Year
-0.00
from -0.02
EPS Next Year
0.01
from -0.00
EPS and Forward PE are based on non-GAAP adjusted numbers.